1. Home
  2. POET vs SANA Comparison

POET vs SANA Comparison

Compare POET & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$14.10

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$3.04

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
SANA
Founded
1972
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
POET
SANA
Price
$14.10
$3.04
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.80
AVG Volume (30 Days)
59.8M
3.8M
Earning Date
08-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.24
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$848.96
N/A
Revenue Next Year
$700.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$1.98
52 Week High
$20.65
$6.55

Technical Indicators

Market Signals
Indicator
POET
SANA
Relative Strength Index (RSI) 57.84 39.07
Support Level $5.50 $2.88
Resistance Level $15.50 $3.43
Average True Range (ATR) 2.05 0.21
MACD 0.63 -0.05
Stochastic Oscillator 55.11 12.58

Price Performance

Historical Comparison
POET
SANA

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Share on Social Networks: